VS Conventional Gum Graft Upper Anteriors Before Next day - PDF document

Jan 01, 2024 •392 likes •490 views

Upper Right Before Immediately After Next Day Post-op 1 week post-op 3 weeks post-op 2 months post-op VS Conventional Gum Graft Upper Anteriors Before Next day Immediately after 1 week post-op 6 weeks post-op 1 yr 10 months

  Upper Right Before Immediately After Next Day Post-op 1 week post-op 3 weeks post-op 2 months post-op VS Conventional Gum Graft
  Upper Anteriors Before Next day Immediately after 1 week post-op 6 weeks post-op 1 yr 10 months post-op VS Conventional Gum Graft
  Upper Left Immediately after Before Next day 1 week post-op 6 weeks post-op 3 yrs & 7 months post-op VS Conventional Gum Graft
  Lower Right Immediately after Before Next day 1 week post-op 3 weeks post-op 2 yrs & 10 months post-op VS Conventional Gum Graft
Lower Anteriors immediately after Next day Before 1 week post-op 7 weeks post-op 3 yrs & 3 months post-op VS Conventional Gum Graft
  Lower Left Next day post-op immediately after Before 1 week post-op 5 months post-op 8 weeks post-op VS Conventional Gum Graft
  Full Upper Before Immediately after Next day 4 weeks post-op 8 weeks post-op 2 yrs & 8 months post-op VS Conventional Gum Graft
  Full Lower Before immediately after Next day 3 yrs & 3 months post-op 1 week post-op 7 weeks post-op VS Conventional Gum Graft
Full Mouth Next day post-op Before Immediately after 1 week post op 6 week post op 1 yr 10 months post op VS Conventional Gum Graft

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

7/27/2018 Introducing a Peptide enhanced bone graft with a unique mechanism of action Current

7/27/2018 Introducing a Peptide enhanced bone graft with a unique mechanism of action Current Solutions in Spine Surgery, May 2018 Jeffrey G. Marx, Ph.D. CONFIDENTIAL 0 Faculty Disclosure I am President and COO of Cerapedics. CONFIDENTIAL

518 views • 7 slides

EVALUATION OF ROOTSTOCKS FOR MANAGEMENT OF MELOIDOGYNE INCOGNITA ON GRAFTED BELL PEPPER M.G.

EVALUATION OF ROOTSTOCKS FOR MANAGEMENT OF MELOIDOGYNE INCOGNITA ON GRAFTED BELL PEPPER M.G. Bausher*, N. Kokalis-Burelle, and E. N. Rosskopf USDA, ARS, U.S. Horticultural Research Laboratory, Fort Pierce, Fl. 34945 Introduction Using germplasm

302 views • 3 slides

CORPORATE PRESENTATION 29 TH ANNUAL PIPER JAFFRAY HEALTHCARE CONFERENCE NOVEMBER 28, 2017 1

DEPLOYING SYSTEM-BASED TECHNOLOGY FOR PERSONALIZED SPINAL CARE CORPORATE PRESENTATION 29 TH ANNUAL PIPER JAFFRAY HEALTHCARE CONFERENCE NOVEMBER 28, 2017 1 11/27/2017 SAFE HARBOR This document has been prepared by MEDICREA International (the

480 views • 31 slides

Organ transplantation in AL Amyloidosis Andrea Havasi, MD Boston University Renal Section

Organ transplantation in AL Amyloidosis Andrea Havasi, MD Boston University Renal Section Disclosure of Conflict of Interest I do not have a relationship with a for-profit and/or a not-for- profit organization to disclose Renal Involvement

443 views • 42 slides

Therapeutic and Management Strategies for AMR: A UCLA Cross-Disciplinary Workshop to improve

Therapeutic and Management Strategies for AMR: A UCLA Cross-Disciplinary Workshop to improve diagnosis and treatment of Acute and Chronic AMR Friday, Nov. 8, from 12 - 5 p.m. Tamkin Auditorium, B-130 / Ronald Reagan UCLA Medical Center

1.03k views • 86 slides

approach: A versatile option for complex Aortic Endorepair Nilo J Mosquera, MD.

The inner Branch approach: A versatile option for complex Aortic Endorepair Nilo J Mosquera, MD. www.critical-issues-congress.com Disclosure Speaker name: Nilo J Mosquera, MD. I have the following potential conflicts of interest to

602 views • 37 slides

Curing Sickle Cell Disease: Bone Marrow Transplant, The Clinical Perspective Courtney D.

Curing Sickle Cell Disease: Bone Marrow Transplant, The Clinical Perspective Courtney D. Fitzhugh, M.D. Investigator Lasker Clinical Research Scholar Laboratory of Early Sickle Mortality Prevention Sickle Cell Disease Has an Immense Global

627 views • 38 slides

Focus on Utility: Maximizing Long-Term Survival Jorge D Reyes, MD Chief Division of

Focus on Utility: Maximizing Long-Term Survival Jorge D Reyes, MD Chief Division of Transplantation University of Washington Disclosure I have nothing to disclose. Learning Objectives 1. Become aware of optimization techniques for organ

415 views • 28 slides

Personalizing Care Plans for Survivors Who Receive Hematopoietic Cell Transplant for Cancer

Personalizing Care Plans for Survivors Who Receive Hematopoietic Cell Transplant for Cancer Treatment Karen L Syrjala, PhD ksyrjala@fredhutch.org Barry A Schatz bschatz@illinois.edu Member, Director of Biobehavioral Sciences Bone Marrow

491 views • 26 slides

Engraftment Annette Trickett Principal Scientist | BMT Laboratory | NSW Health Pathology, Randwick

Engraftment Annette Trickett Principal Scientist | BMT Laboratory | NSW Health Pathology, Randwick Hospitals 25 May 2018 Scope Aim: Provide a better understanding of the engraftment timeline and impacting factors Objectives: Define

613 views • 17 slides

Bechara George Mfarrej Bechara George Mfarrej ESR 8 Milan ESR 8 Milan M.Sc. Molecular Biology in

Bechara George Mfarrej Bechara George Mfarrej ESR 8 Milan ESR 8 Milan M.Sc. Molecular Biology in Beirut ( 2004 ) 2 -year experience in Boston ( 2009-2011 ): Basic science projects: transplant and pregnancy mouse models

847 views • 3 slides

Summary of COVID-19 Emergency Operational and IT Modifications OPTN Executive Committee June 7,

Summary of COVID-19 Emergency Operational and IT Modifications OPTN Executive Committee June 7, 2020 Teleconference Presented by: Amber R. Wilk, PhD UNOS Research Department 1 Data items covered today Operational changes Updates

220 views • 10 slides

A Risk skier W World? I ? Its He s Here A Global R Risk sks s and T nd Tren ends F

Global Risk Institute A Risk skier W World? I ? Its He s Here A Global R Risk sks s and T nd Tren ends F Framework May 10, 2017 Lois Tullo Executive in Residence Stephen Hart Previous CRO BNS Global Risks and Trends Framework

625 views • 16 slides

Investor Presentation March 2018 September 2017 Forward Looking Statements 2 This presentation

Investor Presentation March 2018 September 2017 Forward Looking Statements 2 This presentation contains certain "forward looking statements". These statements relate to future events or future performance and reflect the Company's

383 views • 23 slides

Investor Presentation November 2018 Disclaimer and Cautionary Note Regarding Forward- Looking

Investor Presentation November 2018 Disclaimer and Cautionary Note Regarding Forward- Looking Statements This presentation (Presentation) is confidential and contains proprietary non-public information regarding PharmaCielo Ltd. (the

405 views • 23 slides

OGI Investor Presentation OGI: NASDAQ TSX Cautionary Statement This document is current as of

OGI Investor Presentation OGI: NASDAQ TSX Cautionary Statement This document is current as of December 17, 2019, except where otherwise stated. The information contained financial and operational performance of the Company. These include cost

572 views • 25 slides

Corporate Presentation March 2019 TSXV: ALEF OTC: ALEAF Aleafia Health Inc Confidential

Corporate Presentation March 2019 TSXV: ALEF OTC: ALEAF Aleafia Health Inc Confidential & Proprietary Certain Statements herein relating to the Company constitute forward looking statements within the meaning of Certain

349 views • 19 slides

STAGE SETTING (OR AIMS OF OUR PROJECT) Create carrier bacteria able to deliver chosen genes

STAGE SETTING (OR AIMS OF OUR PROJECT) Create carrier bacteria able to deliver chosen genes into eukaryotic cell Bacteria enter the eukaryotic cell, then decompose and release plasmid that is used by the cell to produce given protein

640 views • 30 slides

FrankWood Gatsby UCL

FrankWood Gatsby UCL CedricArchambeau Gatsby JanGasthaus HKUST LancelotJames Gatsby YeeWhye Teh

549 views • 34 slides

Student Recital Planning Request a Date Check the website for available recital dates

Student Recital Planning Request a Date Check the website for available recital dates music.cmich.edu --> Current Students --> Student Recitals Fill and sign the Student Recital Request Form return to Kristin Pagels Check

214 views • 10 slides

Bridge By: Mr. Chung KHChung@interact.ccsd.net Main Materials: Grid paper (12x18)

Design and Build Your Model Bridge By: Mr. Chung KHChung@interact.ccsd.net Main Materials: Grid paper (12x18) T-pin Pencil (# 2, or 2-H) Wax paper Ruler (metric) Sand paper Cutting tools Bull nose clamp

582 views • 34 slides

Perplexity on Reduced Corpora Analysis of Cutoff by Power Law Hayato Kobayashi Yahoo Japan

Perplexity on Reduced Corpora Analysis of Cutoff by Power Law Hayato Kobayashi Yahoo Japan Corporation Cutoff Removing low-frequency words from a corpus Common practice to save computational costs in learning Language modeling

344 views • 32 slides

Hand Washing T O P R O T E C T T H E C U S T O M E R S H E A L T H P R E S E N T E D B Y

Hand Washing T O P R O T E C T T H E C U S T O M E R S H E A L T H P R E S E N T E D B Y O . P E T E R S N Y D E R , J R . , P H . D . H O S P I T A L I T Y I N S T I T U T E O F T E C H N O L O G Y A N D M A N A G E M E N T

217 views • 17 slides

Joshua Hartigan Supervisor: Judy-anne Osborn Heres a matrix And heres its Gram

Joshua Hartigan Supervisor: Judy-anne Osborn Heres a matrix And heres its Gram matrix In general, the Gram matrix is G= RR T Gram matrices relate to determinants and high determinants are interesting to

773 views • 41 slides